Cullinan Therapeutics (CGEM) Q3 2025 Earnings

7AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-1.07
-0.94
-0.82
-0.69

Details

Expected EPS
-0.858476
Actual EPS
-1.07
Surprise EPS
-0.21
Surprise Percent
+24.64%

Description

Cullinan Therapeutics (CGEM) has reported earnings of -1.07 per share for Q3 2025.

0 Comments

Share your thoughts